Blog

Discover state-by-state atopic dermatitis data in the National Eczema Association’s 2026 report, revealing prevalence, treatment trends, and more.

Discover the latest Phase 3 and long-term data on obefazimod for ulcerative colitis, unveiling promising results at UEG Week 2026...

Barzolvolimab shows promising phase 3 trial results in treating chronic spontaneous urticaria, significantly reducing symptoms in patients unresponsive to antihistamines.

Discover the truth about at-home dermarollers! We separate skin care facts from social media myths to help you use microneedling...

Clascoterone 5% topical solution shows safe, effective results for male hair loss, offering promising long-term treatment for androgenetic alopecia.

Sol-Gel Technologies completes phase 3 trial of patidegib gel for Gorlin syndrome, aiming to prevent basal cell carcinoma with a...

Discover effective pediatric psoriasis treatments from topicals to new oral and injectable therapies, plus tips on managing teen adherence and...

Discover how Alopecia Awareness Month highlights the emotional support needed beyond treatment for alopecia areata patients and their mental well-being.